Why Is Nutraceuticals Player Cosmos Health Stock Trading Higher Today?
Portfolio Pulse from Vandana Singh
Cosmos Health Inc (NASDAQ:COSM) has announced its inaugural 2026 revenue and EBITDA guidance, forecasting over $180 million in gross annual revenue and EBITDA in excess of $20 million. The company's CEO, Greg Siokas, stated that the projection was based on their long-term outlook to achieve substantial growth and profitability. The company's shares are up 16.20% at $1.15.
September 12, 2023 | 2:47 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cosmos Health Inc's announcement of its 2026 revenue and EBITDA guidance has led to a 16.20% increase in its share price.
The company's announcement of its 2026 revenue and EBITDA guidance, which forecasts substantial growth and profitability, has likely led to increased investor confidence, resulting in a 16.20% increase in its share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100